Bayer Withdraws Controversial Heart Surgery Drug After FDA Request

The New York Times reported that Bayer A.G. announced that it will withdraw one of its medications used in heart surgery, as it was found to increase the risk of death. The drug, Trasylol, administered to heart surgery patients to reduce excessive bleeding, was found to increase death rates by a Canadian medical study. According to the article, researchers from the Ottawa Health Institute stopped a study of Trasylol in 3,000 heart and valve surgery patients two weeks ago because of the increased death rates.  And last year, The New England Journal of Medicine published a study of Trasylol which concluded that the drug increased the risks of kidney failure, heart attack and stroke.

Leave a Reply

Your email address will not be published. Required fields are marked *